edetic acid has been researched along with Cardiovascular Diseases in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (33.33) | 18.7374 |
| 1990's | 5 (15.15) | 18.2507 |
| 2000's | 5 (15.15) | 29.6817 |
| 2010's | 9 (27.27) | 24.3611 |
| 2020's | 3 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Anstrom, KJ; Lamas, GA; Navas-Acien, A; Pinotti, R; Ravalli, F; Ujueta, F; Vela Parada, X | 1 |
| Yen, JS; Yen, TH | 1 |
| Lamas, GA; Mann, KK; Navas-Acien, A; Prashad, R; Ujueta, F | 1 |
| Jahangir, A; Mookadam, F; Murarka, S; Sultan, S; Tajik, AJ | 1 |
| Bangalore, S; Farkouh, M; Mathew, RO; Newman, JD; Nichols, EL; Schulman-Marcus, J; Sidhu, MS | 1 |
| Aude, YW; Diaz, D; Fonseca, V; Lamas, GA | 1 |
| Calderon Moreno, R; Diaz, D; Escolar, E; Fonseca, V; Lamas, GA; Nathan, DM; Navas-Acien, A; Newman, J; Schmedtje, JF | 1 |
| Baynes, JW; Frizzell, N | 1 |
| Arenas, I; Lamas, GA; Peguero, JG | 1 |
| Akin, F; Altun, I; Kalemci, S; Kose, N | 1 |
| Culotta, VL; Gottlieb, SH; Navas-Acien, A; Ouyang, P | 1 |
| Lamas, GA; Lee, KL; Mark, DB; Navas-Acien, A | 1 |
| Lieberman, LL; Moscicki, HE | 1 |
| CLARKE, NE; MOSHER, RE | 1 |
| CLARKE, NE | 1 |
| BOYLE, AJ; CLARKE, NE; McCANN, DS; MOSHER, RE | 1 |
| JORNS, G | 1 |
| PERRY, HM | 2 |
| Brouns, RM; de Jonge, R; Griffioen, PH; Lindemans, J; van Zelst, B; Visser, W | 1 |
| Mills, EJ; Seely, DM; Wu, P | 1 |
| Espinosa, IL; Macfarlane, RD; McNeal, CJ | 1 |
| Cheraskin, E; McDonagh, EW; Rudolph, CJ | 1 |
| Barbas, C; Bonet, B; Bonet, MV; Castro, M; Fraile, MV; Herrera, E; Viana, M | 1 |
| Feddersen, S; Flytlie, KT; Hancke, C | 1 |
| Lewin, MR | 1 |
| Anandasbapathy, S; Elihu, N; Frishman, WH | 1 |
| Anderson, MW; Borello, JA; Bova, JG; Brown, JJ; Chezmar, JL; Dachman, AH; Federle, MP; Fenstermacher, M; Foster, GS; Francis, IR; Freeny, PC; Halford, HH; Harmon, B; Harms, SE; Johnson, CD; Kenney, PJ; Klippenstein, DL; Lee, JK; Mattrey, R; Mitchell, DG; Pelsang, RE; Rubin, DL; Saini, S; Semelka, RC; Turner, DA; Weinreb, JC | 1 |
| Thompson, LJ | 1 |
| Platts-Mills, A | 1 |
| Beattie, AD; Goldberg, A | 1 |
| Garas, Z; Kanyár, B; Komor, K | 1 |
13 review(s) available for edetic acid and Cardiovascular Diseases
| Article | Year |
|---|---|
Chelation Therapy in Patients With Cardiovascular Disease: A Systematic Review.
Topics: Adult; Cardiovascular Diseases; Chelation Therapy; Edetic Acid; Humans; Prospective Studies; Quality of Life; Randomized Controlled Trials as Topic; Retrospective Studies | 2022 |
Low-Level Metal Contamination and Chelation in Cardiovascular Disease-A Ripe Area for Toxicology Research.
Topics: Cardiovascular Diseases; Chelating Agents; Chelation Therapy; Edetic Acid; Humans; Metals | 2021 |
Chelation therapy in cardiovascular disease: an update.
Topics: Animals; Atherosclerosis; Cardiovascular Diseases; Chelating Agents; Chelation Therapy; Coronary Artery Disease; Edetic Acid; Humans; Myocardial Infarction; Off-Label Use; Randomized Controlled Trials as Topic; Treatment Outcome | 2017 |
Chelation Therapy as a Cardiovascular Therapeutic Strategy: the Rationale and the Data in Review.
Topics: Cardiovascular Diseases; Chelating Agents; Chelation Therapy; Complementary Therapies; Edetic Acid; Humans; Metals, Heavy | 2017 |
Chelation therapy to prevent diabetes-associated cardiovascular events.
Topics: Atherosclerosis; Cardiovascular Diseases; Chelating Agents; Chelation Therapy; Diabetes Mellitus; Diabetic Cardiomyopathies; Edetic Acid; Glycation End Products, Advanced; Humans; Metals; Myocardial Infarction; National Institutes of Health (U.S.); Oxidation-Reduction; Randomized Controlled Trials as Topic; United States | 2018 |
Potential Role of Metal Chelation to Prevent the Cardiovascular Complications of Diabetes.
Topics: Antioxidants; Arsenic; Ascorbic Acid; Atherosclerosis; Cadmium; Calcium Chelating Agents; Cardiovascular Diseases; Chelating Agents; Chelation Therapy; Copper; Diabetes Complications; Diabetes Mellitus; Edetic Acid; Glycation End Products, Advanced; Hospitalization; Humans; Iron; Lead; Lipid Metabolism; Mercury; Myocardial Infarction; Myocardial Revascularization; Oxidative Stress; Randomized Controlled Trials as Topic; Stroke | 2019 |
EDTA Chelation Therapy to Reduce Cardiovascular Events in Persons with Diabetes.
Topics: Cardiovascular Diseases; Chelating Agents; Chelation Therapy; Diabetes Complications; Edetic Acid; Humans; Metals; Metals, Heavy; Oxidative Stress; Randomized Controlled Trials as Topic | 2015 |
Heavy Metals, Cardiovascular Disease, and the Unexpected Benefits of Chelation Therapy.
Topics: Calcium Chelating Agents; Cardiovascular Diseases; Chelation Therapy; Diabetes Complications; Edetic Acid; Environmental Exposure; Humans; Metals, Heavy; Randomized Controlled Trials as Topic | 2016 |
EDTA chelation therapy for cardiovascular disease: a systematic review.
Topics: Cardiovascular Diseases; Chelating Agents; Chelation Therapy; Edetic Acid; Humans; Randomized Controlled Trials as Topic | 2005 |
Chelation therapy for cardiovascular disease. Review and commentary.
Topics: American Heart Association; Cardiovascular Diseases; Chelating Agents; Chelation Therapy; Complementary Therapies; Edetic Acid; Humans; United States | 1997 |
Chelation therapy in cardiovascular disease: ethylenediaminetetraacetic acid, deferoxamine, and dexrazoxane.
Topics: Antibiotics, Antineoplastic; Cardiovascular Diseases; Chelating Agents; Chelation Therapy; Deferoxamine; Doxorubicin; Edetic Acid; Female; Humans; Iron; Razoxane | 1998 |
[Role of lead in medicine].
Topics: Adolescent; Adult; Aged; Air Pollution; Anemia; Cardiovascular Diseases; Child; Child, Preschool; Edetic Acid; Humans; Infant; Infant, Newborn; Kidney Diseases; Lead Poisoning; Mental Disorders; Middle Aged; Nervous System Diseases; Penicillamine; United States; Urban Population | 1974 |
Cardiovascular diseases related to geochemical environment. Hypertension and the geochemical environment.
Topics: Animals; Cadmium; Cadmium Poisoning; Cardiovascular Diseases; Edetic Acid; England; Environment; Environmental Health; Female; Geological Phenomena; Geology; Humans; Hypertension; Japan; Kidney; Middle Aged; Protein Binding; Rats; Socioeconomic Factors; United States; Wales; Water Supply | 1972 |
2 trial(s) available for edetic acid and Cardiovascular Diseases
| Article | Year |
|---|---|
Evaluation of a shorter methionine loading test.
Topics: Administration, Oral; Adult; Cardiovascular Diseases; Chelating Agents; Edetic Acid; Fasting; Female; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Linear Models; Methionine; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Pre-Eclampsia; Pregnancy; Risk Factors; Time Factors | 2004 |
Safety and efficacy of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: results of the U.S. multicenter phase III clinical trials (safety).
Topics: Abdominal Pain; Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Contrast Media; Diagnosis, Differential; Edetic Acid; Female; Humans; Image Enhancement; Injections, Intravenous; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Pain; Pregnancy; Pyridoxal Phosphate; Risk Assessment; Sensitivity and Specificity; Vomiting | 2000 |
18 other study(ies) available for edetic acid and Cardiovascular Diseases
| Article | Year |
|---|---|
Chelation trial in patients with cardiovascular disease.
Topics: Cardiovascular Diseases; Chelating Agents; Chelation Therapy; Clinical Trials as Topic; Edetic Acid; Humans; Myocardial Infarction | 2023 |
Chelation therapy: overlooked in the treatment and prevention of diabetes complications?
Topics: Advanced Oxidation Protein Products; Animals; Cardiovascular Diseases; Catalysis; Chelation Therapy; Diabetes Complications; Diabetes Mellitus, Type 2; Disease Models, Animal; Edetic Acid; Glycation End Products, Advanced; Humans; Metals; Reactive Oxygen Species | 2013 |
Chelation therapy and cardiovascular disease: connecting scientific silos to benefit cardiac patients.
Topics: Cardiovascular Agents; Cardiovascular Diseases; Chelating Agents; Chelation Therapy; Drug Therapy, Combination; Edetic Acid; Endpoint Determination; Evidence-Based Medicine; Female; Health Services Needs and Demand; Humans; Male; Metals, Heavy; Middle Aged; Outcome Assessment, Health Care; Randomized Controlled Trials as Topic; United States; Vitamins; Xenobiotics | 2014 |
Hematologic parameters in patients with sarcoidosis.
Topics: Blood Cell Count; Bone Marrow; Cardiovascular Diseases; Edetic Acid; Glomerular Filtration Rate; Hematologic Diseases; Humans; Lymphocytes; Mean Platelet Volume; Neutrophils; Sarcoidosis; Spleen | 2017 |
Bound together for health. An introduction to chelation therapy.
Topics: Aged; Aged, 80 and over; Arthritis; Cardiovascular Diseases; Chelation Therapy; Combined Modality Therapy; Complementary Therapies; Diabetic Angiopathies; Edetic Acid; Humans; Male; Nurse Practitioners; Patient Selection; Primary Health Care; Safety | 2001 |
Treatment of occlusive vascular disease with disodium ethylene diamine tetraacetic acid (EDTA).
Topics: Cardiovascular Diseases; Edetic Acid; Ethylenediamines; Ethylenes; Humans; Peripheral Vascular Diseases; Vascular Diseases | 1960 |
Atherosclerosis, occlusive vascular disease and EDTA.
Topics: Atherosclerosis; Cardiovascular Diseases; Edetic Acid; Humans; Peripheral Vascular Diseases; Vascular Diseases | 1960 |
Chelation therapy in circulatory and sclerosing diseases.
Topics: Cardiovascular Diseases; Chelation Therapy; Edetic Acid; Humans; Sclerosis | 1961 |
[Iontophoresis in arterial circulatory disorders and post-traumatic edema].
Topics: Arteries; Cardiovascular Diseases; Edema; Edetic Acid; Iontophoresis; Peripheral Vascular Diseases; Vascular Diseases | 1961 |
Chelation therapy in circulatory and sclerosing diseases.
Topics: Cardiovascular Diseases; Chelation Therapy; Edetic Acid; Humans | 1961 |
Method for lipoprotein(a) density profiling by BiEDTA differential density lipoprotein ultracentrifugation.
Topics: Bismuth; Blotting, Western; Cardiovascular Diseases; Centrifugation, Density Gradient; Chromatography, Affinity; Edetic Acid; Humans; Lipoprotein(a); Protein Isoforms; Ultracentrifugation | 2006 |
The influence of EDTA salts plus multivitamin-trace mineral therapy upon total serum cholesterol/high-density lipoprotein cholesterol.
Topics: Cardiovascular Diseases; Cholesterol; Edetic Acid; Humans; Hypercholesterolemia; Lipoproteins, HDL; Middle Aged; Trace Elements; Vitamins | 1982 |
In vitro effects of a flavonoid-rich extract on LDL oxidation.
Topics: Antioxidants; Butylated Hydroxytoluene; Cardiovascular Diseases; Copper; Edetic Acid; Flavonoids; Humans; Lipid Peroxidation; Lipoproteins, LDL; Oxidation-Reduction; Plant Extracts; Plants, Medicinal; Thiobarbituric Acid Reactive Substances; Vitamin E | 1996 |
[EDTA chelation--a medical treatment and a surgical problem].
Topics: Cardiovascular Diseases; Chelating Agents; Edetic Acid; Humans; Risk Factors | 1997 |
Chelation therapy.
Topics: Cardiovascular Diseases; Drug Evaluation; Edetic Acid; Humans | 1990 |
EDTA chelation therapy.
Topics: Aged; Cardiovascular Diseases; Edetic Acid; Humans | 1988 |
[51Cr-EDTA and endogenous creatine clearance studies].
Topics: Cardiovascular Diseases; Chromium Radioisotopes; Creatine; Diabetes Mellitus; Diagnostic Errors; Edetic Acid; Glomerular Filtration Rate; Heart Diseases; Humans; Hypertension; Kidney Diseases; Kidney Function Tests | 1974 |
[Scientific conference on the recent advances of the pharmacodynamics of the cardiovascular agents and on the pharmacotherapy of cardiovascular diseases].
Topics: Anti-Arrhythmia Agents; Cardiovascular Diseases; Edetic Acid; Histamine H1 Antagonists; Humans; Poland; Vasoconstrictor Agents | 1966 |